| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.31 | 0.07 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.093 | 0.08 |